ClinicalTrials.Veeva

Menu

Sevoflurane in Electroconvulsive Therapy

I

Inonu University

Status and phase

Completed
Phase 4

Conditions

ECT
Anesthesia

Treatments

Drug: sevorane

Study type

Interventional

Funder types

Other

Identifiers

NCT01905904
ulkü_2

Details and patient eligibility

About

The purpose of the study was to investigate the effects of different doses of sevoflurane used in electroconvulsive therapy (ECT) on duration of seizure, hemodynamic response and recovery profiles

Full description

Motor (EMG) and electroencephalography seizure duration (EEG), heart rate (HR) and mean arterial pressure (MAP) values, and recovery times were recorded.

Enrollment

25 patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Study included 25 patients of American Society of Anesthesiologists (ASA) physical status I-II aged between 18-60 years who were scheduled for ECT sessions under general anesthesia

Exclusion criteria

  • Pregnancy
  • Cerebrovascular disease
  • Epilepsy
  • Unstable cardiovascular disease
  • Chronic obstructive pulmonary disease; and
  • Renal or hepatic failure

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

25 participants in 2 patient groups

sevorane
Active Comparator group
Description:
Sevorane 4% concentration during anesthesia induction
Treatment:
Drug: sevorane
sevorane %7
Active Comparator group
Description:
Sevorane 7% concentration during anesthesia induction
Treatment:
Drug: sevorane

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems